Amendment to Schedule 13D for Gyrodyne, LLC

This filing is an amendment to the Schedule 13D for Gyrodyne, LLC, filed by Star Equity Fund, LP and related entities. The amendment includes a settlement agreement between Star Equity and Gyrodyne, LLC, dated October 16, 2025. The agreement outlines the withdrawal of Star Equity's nomination of two candidates for the board of directors at the 2025 annual meeting. In exchange, Gyrodyne, LLC agreed to nominate only one director, Richard B. Smith, and reduce the board size from five to four directors. The agreement also includes standstill provisions, limiting Star Equity's actions regarding board nominations and shareholder proposals until December 31, 2026, or December 31, 2027, under certain conditions. Additionally, the filing includes a joint filing agreement among the reporting persons.